Edition:
United Kingdom

People: Prometic Life Sciences Inc (PLI.TO)

PLI.TO on Toronto Stock Exchange

0.06CAD
22 Apr 2019
Change (% chg)

$0.01 (+20.00%)
Prev Close
$0.05
Open
$0.05
Day's High
$0.06
Day's Low
$0.05
Volume
8,096,969
Avg. Vol
2,156,458
52-wk High
$1.01
52-wk Low
$0.05

Bishop, Andrew 

Mr. Andrew Bishop serves as Independent Director of the Company. Mr. Andrew Bishop is a Partner and Co-Founder of Bingley Capital Inc., and brings over 20 years of experience in advising biotech and health care companies. He has worked on over 100 financing and M&A transactions over his career. Prior to establishing Bingley Capital in 2009, he held senior roles in investment banking, including Head of Health Care Investment Banking at HSBC Securities (Canada) Inc., where he covered biotech, pharma, and specialty pharma companies. He started his career in investment banking focused on companies in Quebec. For the past nine years, Mr. Bishop served as a Director and Chair of Willow Breast & Hereditary Cancer Support, a not-for-profit organization focused on breast and hereditary cancer. Mr. Bishop received an International M.B.A. (with Distinction) from the Schulich School of Business at York University, and a Bachelor of Arts in Political Science and Economics from McGill University. He also received his Chartered Financial Analyst designation.

Basic Compensation

Total Annual Compensation, CAD 53,850
Restricted Stock Award, CAD --
Long-Term Incentive Plans, CAD --
All Other, CAD 84,409
Fiscal Year Total, CAD 138,259

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Simon Best

277,333

Bruce Pritchard

2,711,580

John Moran

1,837,760

Bruce Wendel

121,072

Patrick Sartore

2,119,760

Stefan Clulow

121,072
As Of  31 Dec 2017